Locked In Upper Circuit Limit: IT Stock Trading At Rs 20 Okays FCCBs To Raise USD 50 Million

Blue Cloud Softech Solutions Ltd (BCSSL), a Hyderabad-based technology firm, experienced a 2% increase in share price on Friday, reaching its upper circuit at Rs 20.09 from Rs 19.70. This momentum increases the stock's value by 34.4% from its 52-week low of Rs 14.95. BCSSL has garnered attention due to their strategic initiatives alongside the company's market capitalisation of Rs 876.5 crore and a three-year CAGR of 40% as per its latest quarterly results, which have been outperforming expectations.

BCSSL is looking to capture greater international markets as discussed in the latest Board meeting, where it was decided to implement growth-driving measures pending approval in the extraordinary shareholders' meeting.

In a bid to accomplish this, one of the proposals made includes enhancing the Authorised Share Capital, which currently rests at Rs 630 crore, to Rs 800 crore and will be segregated into 80 crore Re 1 equity shares. The capital restructuring will allow BCSSL to accomplish its aggressive growth strategies.

In an important strategic move, the Board gave a green light to a preferential allotment to issue 32 crore equity shares for AIS Anywhere, a New Jersey-based global technology solutions firm. The buyout will be executed through a share swap agreement where BCSSL will pay Rs 752.32 crore and acquire AIS Anywhere by exchanging 5 equity shares of BCSSL for every share of AIS bought. After the transaction, BCSSL will have full ownership of AIS Anywhere, which will function as BCSSL's subsidiary.

This is advantageous to BCSSL as it now has the ability to utilize the skills and capabilities of AIS Anywhere in artificial intelligence, data science and analytics, cybersecurity, Internet of Things, and enterprise technology solutions, thus broadening BCSSL's service capabilities at the international level and expanding its presence in the US markets.

Moreover, the Board of Directors has authorized the company to allocate capital of up to Rs 1,300 crores for Indian and foreign ventures, which is a deviation from the general thresholds under Section 186 of the Companies Act 2013. This demonstrates BCSSL's willingness to leap and seek aggressive spending choices that coincide with its roadmap.

In addition, the company, awaiting regulatory and shareholder approvals, intends to raise up to USD 50 million via Foreign Currency Convertible Bonds (FCCBs) to further catalyse expansion.

With respect to the net earnings of BCSSL for Q3FY25, the results have been remarkable, revealing net sales to account for Rs 235.27 Crores while the net earnings profit for YoY stood at Rs 9.4 Crores, which is a 131% increase. In the first 9 months of FY25, net sales also saw a growth of 112%, reaching Rs 613.24 Crores, while net profit also soared 316% to Rs 31.23 Crores, showing the growing company's efficiency in resource management as well as the rising demand in the markets.

This year, the company also did a stock split of 2:1 and split equity shares of Rs 2 each into shares of Re 1 each, effective 20 January 2025.

BCSSL is located in Hyderabad, Telangana and has maintained its reputation as the pioneer of AIoT-based solutions with healthcare and technology products for the healthcare sector, and it's for this reason that the company is beloved. Its innovation enables them to provide the industries and societies with homegrown, life-changing technologies.